Implications of NF2 mutations significantly influencing meningioma progression have prompted clinical trial investigations of inhibition of focal adhesion kinase, thought to be associated with NF2/merlin-mediated tumor growth [11, 22]. This evidence concerns the gene NF2 and meningioma.